Site icon pharmaceutical daily

Teva to Host Conference Call to Discuss First Quarter 2019 Financial Results at 8 a.m. ET on May 2, 2019

JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today
announced that it will issue a press release on its first quarter 2019
financial results on Thursday, May 2, 2019 at 7:00 a.m. ET. Following
the release, Teva will conduct a conference call and live webcast on the
same day, at 8:00 a.m. ET.

In order to participate, please dial the following numbers (at least 10
minutes before the scheduled start time): United States 1-866-966-1396;
Israel 1-809-203-624 or International +44 (0) 2071 928000; passcode: 9470199.
For a list of other international toll-free numbers, click here.

A live webcast of the call will also be available on Teva’s website at: http://ir.tevapharm.com.
Please log in at least 10 minutes prior to the conference call in order
to download the applicable audio software.

Following the conclusion of the call, a replay of the webcast will be
available within 24 hours on the Company’s website by calling United
States 1-866-331-1332; International +44 (0) 3333009785; passcode: 9470199.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been
developing and producing medicines to improve people’s lives for more
than a century. We are a global leader in generic and specialty
medicines with a portfolio consisting of over 35,000 products in nearly
every therapeutic area. Around 200 million people around the world take
a Teva medicine every day, and are served by one of the largest and most
complex supply chains in the pharmaceutical industry. Along with our
established presence in generics, we have significant innovative
research and operations supporting our growing portfolio of specialty
and biopharmaceutical products. Learn more at www.tevapharm.com.

Teva Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995, which
are based on management’s current beliefs and expectations and are
subject to substantial risks and uncertainties, both known and unknown,
that could cause our future results, performance or achievements to
differ significantly from that expressed or implied by such
forward-looking statements. Important factors that could cause or
contribute to such differences include risks relating to:

and other factors discussed in our Annual Report on Form 10-K for the
year ended December 31, 2018, including the sections captioned “Risk
Factors.” Forward-looking statements speak only as of the date on which
they are made, and we assume no obligation to update or revise any
forward-looking statements or other information contained herein,
whether as a result of new information, future events or otherwise. You
are cautioned not to put undue reliance on these forward-looking
statements.

Contacts

IR Contacts
United States
Kevin C. Mannix
(215)
591-8912

Israel
Ran Meir
972 (3) 926-7516

PR Contacts
United States
Kelley Dougherty
(973)
658-0237

Israel
Yonatan Beker
972 (54) 888 5898

Exit mobile version